Abbott's (ABT) footprint in the diabetes care market is increased by the Bigfoot Biomedical acquisition.
There will always be a healthcare industry, and it will always be a place to find great long-term stocks. You probably know healthcare conglomerate Johnson & Johnson for some of its former brands, like Tylenol and Band-Aids.
Abbott Laboratories (NYSE: ABT) is seen as a solid safe-harbor stock because of the company's 135-year history, its diversified healthcare business, and its reliable dividend. Abbott is a global company with a huge reach in products and geography. Its segments are diagnostic products, medical devices, nutritional products, and established pharmaceutical products (branded generic medicines).